---
figid: PMC8429149__18_2021_3909_Fig1_HTML
figtitle: 'IL-36 cytokines in inflammatory and malignant diseases: not the new kid
  on the block anymore'
organisms:
- NA
pmcid: PMC8429149
filename: 18_2021_3909_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8429149/figure/Fig1/
number: F1
caption: 'IL-36R signalling: IL-36 agonists bind to the IL-36R, with activation promoting
  the formation of the IL-36R:IL-1RAcP complexes. IL-36Ra and IL-38 prevents IL-36R
  signalling by inhibiting IL-36:IL-1RAcP heterodimerisation. IL-36R:IL-1RAcP complexes
  induce TIR activation and MyD88 recruitment. The IL-36 signalling pathway occurs
  through the classical MyD88–IRAK–TRAF–TAK–TAB pathway. Phosphorylated TAK1 promotes
  MAPK and NF-κB signalling by inducing MAPK kinase and IKK activation. IKK phosphorylates
  IκB, thus releasing NF-κB while the MAPK kinase activates p38 MAPK, ERK1/2, and
  AP-1 proteins. NF-κB and AP-1 proteins undergo nuclear translocation and promote
  the transcription of inflammatory genes. IL-36 signalling promotes DC maturation,
  Th cell polarisation and anti-tumorigenic responses. Image created with BioRender.com'
papertitle: 'IL-36 cytokines in inflammatory and malignant diseases: not the new kid
  on the block anymore.'
reftext: James Byrne, et al. Cell Mol Life Sci. 2021;78(17-18):6215-6227.
year: '2021'
doi: 10.1007/s00018-021-03909-4
journal_title: Cellular and Molecular Life Sciences
journal_nlm_ta: Cell Mol Life Sci
publisher_name: Springer International Publishing
keywords: Interleukin-36 | IL-1 family | Cytokine | Inflammation | Disease | Cancer
automl_pathway: 0.9516888
figid_alias: PMC8429149__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8429149__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8429149__18_2021_3909_Fig1_HTML.html
  '@type': Dataset
  description: 'IL-36R signalling: IL-36 agonists bind to the IL-36R, with activation
    promoting the formation of the IL-36R:IL-1RAcP complexes. IL-36Ra and IL-38 prevents
    IL-36R signalling by inhibiting IL-36:IL-1RAcP heterodimerisation. IL-36R:IL-1RAcP
    complexes induce TIR activation and MyD88 recruitment. The IL-36 signalling pathway
    occurs through the classical MyD88–IRAK–TRAF–TAK–TAB pathway. Phosphorylated TAK1
    promotes MAPK and NF-κB signalling by inducing MAPK kinase and IKK activation.
    IKK phosphorylates IκB, thus releasing NF-κB while the MAPK kinase activates p38
    MAPK, ERK1/2, and AP-1 proteins. NF-κB and AP-1 proteins undergo nuclear translocation
    and promote the transcription of inflammatory genes. IL-36 signalling promotes
    DC maturation, Th cell polarisation and anti-tumorigenic responses. Image created
    with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRAF6
  - TAB2
  - TAB1
  - MAP3K7
  - NR2C2
  - IL36A
  - IL36B
  - IL1RL2
  - MAPK3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAP2K1
  - MAP2K3
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - MYD88
  - NFKB1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - IL36RN
  - IL1F10
  - TH
---
